Physician profile
Brian Allen Bruckner
NPI 1871573097
$105,751.96
in general payments reported to CMS, 2019-2025
23 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $15K · 2021: $3,025 · 2022: $2,979 · 2023: $3,547 · 2024: $708 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $1,691 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $1,691.16 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up Sa | $47,303.66 | 2019 | |
| Biom'Up France Sas | $18,097.67 | 2020-2021 | |
| Baxter Healthcare | $13,619.94 | 2019-2023 | Coseal |
| Grt US Holding, INC. | $8,000.00 | 2019 | |
| Abbott Laboratories | $6,809.12 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Davol INC. | $6,105.59 | 2019-2024 | Arista Ah Flexitip |
| Dilon Technologies, INC. | $3,122.16 | 2023-2025 | Hemoblast Bellows |
| Abiomed | $1,419.59 | 2019-2025 | Impella |
| Livanova USA, INC. | $410.42 | 2019-2023 | Lifesparc |
| Atricure, INC. | $208.92 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medtronic Vascular, INC. | $199.30 | 2019-2020 | |
| Kerecis Limited | $177.44 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $49.39 | 2024-2025 | Restrata Wound Matrix |
| Convatec INC. | $44.73 | 2023-2024 | |
| La Jolla Pharmaceutical Company | $37.92 | 2024 | Giapreza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $27.63 | 2024 | Irrisept |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Tela Bio, INC. | $19.66 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Angiodynamics, INC. | $19.28 | 2025 | Auryon Laser System 100-120 Vac |
| Abbvie INC. | $16.54 | 2022 | |
| Silk Road Medical, INC. | $16.33 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Actelion Pharmaceuticals US, INC. | $15.15 | 2019 | |
| Ethicon US, LLC | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bruckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.